dacarbazine has been researched along with muramidase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carey, RW; Kunz, VS | 1 |
Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L | 1 |
2 other study(ies) available for dacarbazine and muramidase
Article | Year |
---|---|
Acute non-lymphocytic leukemia (ANLL) following treatment with dacarbazine for malignant melanoma.
Topics: Acute Disease; Dacarbazine; Humans; Leukemia; Male; Melanoma; Middle Aged; Muramidase; Scalp; Skin Neoplasms | 1987 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Muramidase; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Secretory Rate; Statistics, Nonparametric; Vinblastine; Vincristine | 1997 |